Our results showed that, in NAFLD and viral hepatitis patients, even before their albumin levels, total bilirubin, and prothrombin time became abnormal, their IMAT value decreased significantly comparing to the healthy volunteers (P < 0.001). Here, F2 is linked to metabolic dysfunction-associated steatotic liver disease.